NURECA Share Price Target 2050

CAGR-based price projection for Nureca Limited (NURECA) targeting 2050, derived from official NSE exchange closing prices.

Bear Case (11.1% CAGR)
Rs 4,220
2050 Target
Base Case (27.9% CAGR)
Rs 121,802
2050 Target
Bull Case (82.5% CAGR)
Rs 624,837,593
2050 Target

Current Market Snapshot

CMP: Rs 334.25
52W High: Rs 343.95
52W Low: Rs 226.23
1Y CAGR: 63.5%
3Y CAGR: 27.9%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 371 Rs 427 Rs 610
2028 Rs 413 Rs 546 Rs 1,114
2029 Rs 459 Rs 699 Rs 2,033
2030 Rs 510 Rs 893 Rs 3,710
2031 Rs 567 Rs 1,142 Rs 6,771
2032 Rs 630 Rs 1,460 Rs 12,359
2033 Rs 700 Rs 1,867 Rs 22,559
2034 Rs 778 Rs 2,387 Rs 41,175
2035 Rs 865 Rs 3,053 Rs 75,155
2036 Rs 961 Rs 3,903 Rs 137,176
2037 Rs 1,069 Rs 4,990 Rs 250,379
2038 Rs 1,188 Rs 6,381 Rs 457,003
2039 Rs 1,320 Rs 8,158 Rs 834,142
2040 Rs 1,467 Rs 10,431 Rs 1,522,512
2041 Rs 1,631 Rs 13,337 Rs 2,778,953
2042 Rs 1,812 Rs 17,053 Rs 5,072,265
2043 Rs 2,014 Rs 21,803 Rs 9,258,115
2044 Rs 2,239 Rs 27,878 Rs 16,898,308
2045 Rs 2,488 Rs 35,644 Rs 30,843,516
2046 Rs 2,765 Rs 45,575 Rs 56,296,906
2047 Rs 3,074 Rs 58,271 Rs 102,755,525
2048 Rs 3,416 Rs 74,506 Rs 187,553,788
2049 Rs 3,797 Rs 95,262 Rs 342,331,210
2050 Rs 4,220 Rs 121,802 Rs 624,837,593

Other NURECA Price Targets

2025 2026 2027 2028 2030 2035 2040

Frequently Asked Questions

What is the NURECA share price target for 2050?

Based on historical growth analysis, the NURECA share price target for 2050 ranges from Rs 4,220 (conservative) to Rs 121,802 (base case) to Rs 624,837,593 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of NURECA?

The current market price of NURECA (Nureca Limited) is Rs 334.25. The 52-week high is Rs 343.95 and 52-week low is Rs 226.23.

Is NURECA a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for NURECA price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at 11.1% CAGR), Base (27.9% CAGR), and Bull (optimistic at 82.5% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.